Objective:To analyze the general level and components of hospitalization expenses in acute myeloid leukemia(AML) patients,explore affecting factors and measurements on how to control them effectively.Methods:In-hospital cases of AML patients from 2014-2015 were collected and statistical description;non-parametric test and stepwise regression were used.Results:The Chinese drug and western drug accounted the largest proportion of AML hospitalization expenses,followed by laboratory tests and blood & blood products.The proportion of these 3 expenses accounted for 82％ of average hospitalization expense.Length of stay,the number of secondary diagnosis,Health insurance type,complexity of operations and procedures,admission patterns and discharge patterns were influential factors.Conclusion:The hospitalization expense was very high to AML patients.Governments,the society and hospitals should take effective measures to improve the promotion of healthcare quality and release medical burden for patients.%目的:分析急性髓样白血病患者住院费用水平和构成情况,探究住院费用的影响因素及控制措施.方法:利用某院2014-2015年急性髓样白血病患者病例资料,进行统计描述,非参数检验和逐步回归分析.结果:急性髓样白血病住院费用中西药费占比最高(达50.6％),其次是实验室诊断及血液和血液制品费,这三项费用占平均住院费用的比重达82％;住院天数、次要诊断个数、手术和操作复杂程度、医保类型、入院方式和离院方式等是影响住院费用的重要因素.结论:急性髓样白血病患者住院费用较高,建议针对重点影响因素,从疾病诊治、政府和社会支持以及医院内部强化管理等多层面采取措施,促进诊疗质量的提升,减轻患者就医负担.
展开▼
